OverviewSuggest Edit
Oncorus is a biopharmaceutical company focused on developing viral immunotherapies to transform outcomes for cancer patients. Using its two platforms, the company develops a pipeline of intratumorally and intravenously administered product candidates designed to selectively attack and kill tumor cells and stimulate multiple arms of the immune system against tumors.
| Type | Public | |
| Founded | 2015 | |
| HQ | Cambridge, MA, US | Map |
| Website | oncorus.com | |
| Overall Culture | F | More |
Recent NewsAll News
- Oncorus Announces Publication of Preclinical Data Demonstrating Potent Systemic Antitumor Activity of its Clinical Stage Oncolytic Herpes Simplex Viral Immunotherapy Product Candidate ONCR-177
- Oncorus Appoints Scott Canute to its Board of Directors
- Oncorus Appoints Steve Harbin as Chief Operating Officer and Chief of Staff
- Oncorus to Participate in Fireside Chats at Upcoming Piper Sandler Annual Healthcare Conference and Evercore ISI HealthCONx Conference
Key People/Management at Oncorus
Ted Ashburn
John McCabe
Mitchell H. Finer
Christophe Quéva
Lorena Lerner
Stephanie Duncanson
Oncorus Office Locations
Oncorus Financials and Metrics
Oncorus Revenue
| USD | |
|---|---|
Net income (H1, 2020) | (17.2m) |
EBIT (H1, 2020) | (16.7m) |
Market capitalization (8-Feb-2021) | 539.4m |
Closing stock price (8-Feb-2021) | 23.9 |
Cash (30-Jun-2020) | 28.9m |
| USD | FY, 2018 |
|---|---|
Financial Leverage | -0.6 x |
Oncorus Operating Metrics
Show all operating metricsOncorus Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| Oncorus Securities Corporation |
Oncorus Cybersecurity Score
Oncorus Online and Social Media Presence
359 Twitter followers
Oncorus has 359 Twitter Followers. The number of followers has increased 1.5% month over month and increased 4.7% quarter over quarter
Oncorus's Trends
Twitter Engagement Stats for @OncorusInc
99
Tweets
213
Following
359
Followers
1
Tweets last 30 days
4
Avg. likes per Tweet
100%
Tweets with engagement
Oncorus Company Culture
Overall Culture
F
34/100
CEO Rating
F
30/100
Compensation
F
10/100
Oncorus News and Updates
Oncorus Announces Publication of Preclinical Data Demonstrating Potent Systemic Antitumor Activity of its Clinical Stage Oncolytic Herpes Simplex Viral Immunotherapy Product Candidate ONCR-177
Oncorus Appoints Scott Canute to its Board of Directors
Oncorus Appoints Steve Harbin as Chief Operating Officer and Chief of Staff
Oncorus to Participate in Fireside Chats at Upcoming Piper Sandler Annual Healthcare Conference and Evercore ISI HealthCONx Conference
Oncorus Reports Third Quarter 2020 Financial Results and Provides Business Highlights
Oncorus to Present at Chardan 4th Annual Genetic Medicines Conference
Oncorus Frequently Asked Questions
When was Oncorus founded?
Oncorus was founded in 2015.
Who are Oncorus key executives?
Oncorus's key executives are Ted Ashburn, John McCabe and Mitchell H. Finer.
How many employees does Oncorus have?
Oncorus has 51 employees.
Who are Oncorus competitors?
Competitors of Oncorus include Invectys, Alpine Immune Sciences and Incanthera.
Where is Oncorus headquarters?
Oncorus headquarters is located at 50 Hampshire St #401, Cambridge.
Where are Oncorus offices?
Oncorus has an office in Cambridge.
How many offices does Oncorus have?
Oncorus has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies